Inmaculada Ballester Navarro

Carmona-Bayonas A, Rodriguez-Gonzalez A, Garcia-Garcia T, Velasco-Durantez V, Hernandez-San Gil R, Cruz-Castellanos P, Fernandez-Montes A, Castillo-Trujillo A, Ballester I, Rogado J, Calderon C, Jimenez-Fonseca P. Can Oncologists Prompt Patient Prognostic Awareness to Enhance Decision-Making? Data From the Neoetic Study. Oncologist. 2023 Apr 26:oyad100. doi: 10.1093/oncolo/oyad100. Online ahead of print. PubMed PMID: 37185783.

AÑO: 2023; IF: 5.8

37185783

Vicente Conesa MA, Zafra Poves M, Carmona-Bayonas A, Ballester Navarro I, de la Morena Barrio P, Ivars Rubio A, Montenegro Luis S, García Garre E, Vicente V, Ayala de la Peña F. A prognostic model to identify short survival expectancy of medical oncology patients at the time of hospital discharge. ESMO Open. 2022 Feb 7;7(1):100384. doi: 10.1016/j.esmoop.2022.100384. [Epub ahead of print] PubMed PMID: 35144121.

AÑO: 2022; IF: 6.883

35144121

Rosino A, Ballester I, Tudela J, González-Billalabeitia E. [Chemotherapy in metastatic castration resistant prostate cancer.]. Arch Esp Urol. 2018 Sep;71(8):676-684. Spanish. PubMed PMID: 30319127.

AÑO: 2018; IF: 0.335

30319127

Chen-Liang TH, Martín-Santos T, Jerez A, Rodríguez-García G, Senent L, Martínez-Millán C, Muiña B, Orero M, Teruel A, Martín A, Gómez-Espuch J, Kennedy K, Benet C, Raya JM, Fernández-González M, de la Cruz F, Guinot M, Villegas C, Ballester I, Baile M, Moya M, López-Jiménez J, Frutos L, Navarro JL, Uña J, Fernández-López R, Igua C, Contreras J, Sánchez-Vañó R, Cozar MDP, Tamayo P, Mucientes J, Sánchez-Blanco JJ, Pérez-Ceballos E, Ortuño FJ. Bone marrow biopsy superiority over PET/CT in predicting progression-free survival in a homogeneously-treated cohort of diffuse large B-cell lymphoma. Cancer Med. 2017 Nov;6(11):2507-2514. doi: 10.1002/cam4.1205. Epub 2017 Sep 27. PubMed PMID: 28960797; PubMed Central PMCID: PMC5673915.

AÑO: 2017; IF: 3.202

28960797